Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2021

Feb 16, 2021

32337_dirs_2021-02-16_92e7557b-df76-43ce-b8a3-61e736e2b696.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE NUTRITION LTD. (HLF)
CIK: 0001180262
Period of Report: 2021-02-11

Reporting Person: LEVY ROBERT (EVP, WW Affairs & Latin Am.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-11 Common Stock M 41666 $26.645 Acquired 570774 Direct
2021-02-11 Common Stock F 30538 $56.66 Disposed 540236 Direct
2021-02-16 Common Stock S 11128 $55.4606 Disposed 529108 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-11 Stock Appreciation Rights $26.645 M 41666 Disposed 2021-05-18 Common Stock (41666) Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $55.12 to $55.74. The price reported reflects the weighted average sale price of $55.4606. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering
20,833 shares at an exercise price of $53.29 per share.

F4: The SARS were granted on May 18, 2011. 20% vested on May 18, 2012, 20% vested on May 18, 2013 and the remaining 60% vested on May 18, 2014.